Magnesium Skin Health Randomized Trial: What the Evidence Says

Quick Answer

Magnesium Skin Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• In this randomized clinical trial, magnesium supplementation significantly accelerated lactate clearance in critically ill patients with sepsis and was associated with reduced vasopressor requirements, shorter intensive care unit stay, and decreased overall hospital stay. [Anbarasan Chakkaravarthe (2026); evidence level 2]
• Table 3 Table 3 vs vs vs P vs P vs P P P P Lactate clearance significantly increased in the M group from day 1 to day 3. [Anbarasan Chakkaravarthe (2026); evidence level 2]
• NLC is strongly associated with secondary insomnia, which can lead to a reduced overall quality of life. [Kuusipalo Arno (2026); evidence level 2]
• Various treatments-such as magnesium supplementation, quinine, massage, exercise, and stretching-have been studied, but evidence for massage and exercise is limited. [Kuusipalo Arno (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For magnesium skin health randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Anbarasan Chakkaravarthe (2026). Impact of magnesium on the clearance of lactate in critically sick patients with sepsis: Randomized clinical trial. DOI: 10.5492/wjccm.v15.i2.115389. PMCID: PMC13248059. PMID: 42272874. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13248059/
• Kuusipalo Arno (2026). Secondary prevention of leg cramps using compression stockings or magnesium supplements: a three-arm randomized clinical trial. DOI: 10.1186/s13063-025-09370-z. PMCID: PMC13005370. PMID: 41680812. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13005370/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.